HTA15 An Assessment of the Evidence Published Post-HTA for Selected HER2-Positive, Early Breast Cancer Medicines, to Address Potential HTA-Body Uncertainties
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1149
https://www.valueinhealthjournal.com/article/S1098-3015(22)01350-X/fulltext
Title :
HTA15 An Assessment of the Evidence Published Post-HTA for Selected HER2-Positive, Early Breast Cancer Medicines, to Address Potential HTA-Body Uncertainties
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01350-X&doi=10.1016/j.jval.2022.04.1149
First page :
Section Title :
Open access? :
No
Section Order :
11027